Dr. James Lawrence Day, PH.D. Psychologist - Clinical Medicare: Not Enrolled in Medicare Practice Location: 415 S Lafayette St, South Lyon, MI 48178 Phone: 248-446-0200 Fax: 248-446-0355 |
Mr. Todd John Nadeau, M.A., LLP Psychologist Medicare: Not Enrolled in Medicare Practice Location: 9287 Silverside, South Lyon, MI 48178 Phone: 586-764-0637 Fax: 810-695-0343 |
Miss Chelsea Ann Williams, M.A. Psychologist - Clinical Medicare: Not Enrolled in Medicare Practice Location: 10944 Mystic View Dr, South Lyon, MI 48178 Phone: 248-486-2822 |
Dave Chatel, LLP Psychologist Medicare: Not Enrolled in Medicare Practice Location: 28900 Pontiac Trl, South Lyon, MI 48178 Phone: 248-560-7507 |
Valerie H Stefanof, MA LLP Psychologist - Mental Retardation & Developmental Disabilities Medicare: Not Enrolled in Medicare Practice Location: 5641 6 Mile Rd, South Lyon, MI 48178 Phone: 248-437-7272 |
Michelle R Burdick Psychologist - Counseling Medicare: Not Enrolled in Medicare Practice Location: 28900 Pontiac Trl, South Lyon, MI 48178 Phone: 734-436-1242 |
News Archive
Acorda Therapeutics, Inc. today announced that the first patient has been enrolled in the first clinical trial of Glial Growth Factor 2 (GGF2). Acorda is collaborating with the Vanderbilt University Heart and Vascular Institute to conduct this Phase 1 single-dose trial in patients with heart failure.
Loyola University Health System will open a Sexual Wellness Clinic in September. This program will combine the expertise of various specialists to address common emotional and physical challenges that couples face in their sexual relationships.
Ligand Pharmaceuticals Incorporated today reported financial results for the first quarter ended March 31, 2012, and provided an operating forecast and program updates.
The National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, has awarded contracts to three organizations to support early-stage human clinical trials of investigational infectious disease treatments. The new awards for the Phase I Clinical Trial Units for Therapeutics increases the number of funded organizations under the program from two to three, expanding capacity for conducting early safety testing of novel investigational drugs.
› Verified 9 days ago